Potential risks of cell-free concentrated ascites reinfusion therapy in TAFRO syndrome patient
Ther Apher Dial
.
2024 Jun;28(3):477-478.
doi: 10.1111/1744-9987.14109.
Epub 2024 Feb 5.
Authors
Kasumi Satoh
1
,
Manabu Okuyama
1
,
Hajime Nakae
1
Affiliation
1
Department of Emergency and Critical Care Medicine, Akita University Graduate School of Medicine, Akita, Japan.
PMID:
38316625
DOI:
10.1111/1744-9987.14109
No abstract available
Publication types
Letter
Case Reports
MeSH terms
Aged
Ascites* / etiology
Ascites* / therapy
Castleman Disease / complications
Castleman Disease / therapy
Cell-Free System
Humans
Male
Primary Myelofibrosis / complications
Primary Myelofibrosis / therapy